Year |
Citation |
Score |
2020 |
Paganoni S, De Marchi F, Chan J, Thrower SK, Staff NP, Datta N, Kisanuki YY, Drory V, Fournier C, Pioro EP, Goutman SA, Atassi N. The NEALS primary lateral sclerosis registry. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 32915077 DOI: 10.1080/21678421.2020.1804591 |
0.324 |
|
2020 |
Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A, Wymer J, Goutman SA, Heitzman D, Heiman-Patterson T, Jackson CE, et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. The New England Journal of Medicine. 383: 919-930. PMID 32877582 DOI: 10.1056/Nejmoa1916945 |
0.324 |
|
2020 |
Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, Glass J, Maragakis NJ, Miller TM, Paganoni S, Rothstein JD, Shefner JM, Simmons Z, Weiss MD, Bedlack RS. Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities. Muscle & Nerve. PMID 32445195 DOI: 10.1002/Mus.26989 |
0.334 |
|
2020 |
De Marchi F, Berry JD, Chan J, Caldwell S, Ellrodt A, Scalia J, Burke K, Fang T, Clark Sisodia R, Schwamm LH, Moura LMVR, Paganoni S. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis. Journal of Neurology. PMID 32125520 DOI: 10.1007/S00415-020-09774-8 |
0.315 |
|
2019 |
Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. Bmc Neurology. 19: 104. PMID 31142272 DOI: 10.1186/S12883-019-1330-6 |
0.318 |
|
2019 |
Berry JD, Paganoni S, Carlson K, Burke K, Weber H, Staples P, Salinas J, Chan J, Green JR, Connaghan K, Barback J, Onnela JP. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Annals of Clinical and Translational Neurology. 6: 873-881. PMID 31139685 DOI: 10.1002/Acn3.770 |
0.341 |
|
2018 |
Nicholson K, Chan J, Macklin EA, Levine-Weinberg M, Breen C, Bakshi R, Grasso DL, Wills AM, Jahandideh S, Taylor AA, Beaulieu D, Ennist DL, Andronesi O, Ratai EM, Schwarzschild MA, ... ... Paganoni S, et al. Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 5: 1522-1533. PMID 30564619 DOI: 10.1002/Acn3.671 |
0.312 |
|
2018 |
Paganoni S, Alshikho MJ, Luppino S, Chan J, Pothier L, Schoenfeld D, Andres PL, Babu S, Zürcher NR, Loggia ML, Barry RL, Luotti S, Nardo G, Trolese MC, Pantalone S, et al. A Pilot Trial of RNS60 in Amyotrophic Lateral Sclerosis. Muscle & Nerve. PMID 30458059 DOI: 10.1002/Mus.26385 |
0.306 |
|
2018 |
Bakshi R, Xu Y, Mueller KA, Chen X, Granucci E, Paganoni S, Sadri-Vakili G, Schwarzschild MA. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1 mutant mice. Molecular and Cellular Neurosciences. PMID 29928993 DOI: 10.1016/J.Mcn.2018.06.002 |
0.337 |
|
2018 |
Burke K, Ellrodt AS, Levine J, Adams T, Allis R, Macmurdie I, Paganoni S. Exploring the use of educational material about shoulder dysfunction: a Quality Improvement project in people with ALS. American Journal of Physical Medicine & Rehabilitation. PMID 29303793 DOI: 10.1097/Phm.0000000000000885 |
0.3 |
|
2018 |
Paganoni S, Alshikho MJ, Zürcher NR, Cernasov P, Babu S, Loggia ML, Chan J, Chonde DB, Garcia DI, Catana C, Mainero C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N. Imaging of glia activation in people with primary lateral sclerosis. Neuroimage. Clinical. 17: 347-353. PMID 29159046 DOI: 10.1016/J.Nicl.2017.10.024 |
0.317 |
|
2017 |
Van De Rijn M, Paganoni S, Levine-Weinberg M, Campbell K, Swartz Ellrodt A, Estrada J, Cohen AB, Schwamm LH, Berry JD. Experience with telemedicine in a multi-disciplinary ALS clinic. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 29250986 DOI: 10.1080/21678421.2017.1392577 |
0.31 |
|
2017 |
Paganoni S, McDonnell E, Schoenfeld D, Yu H, Deng J, Atassi H, Sherman A, Yerramilli-Rao P, Cudkowicz M, Atassi N. Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS). Journal of Neurology & Neurophysiology. 8. PMID 28798889 DOI: 10.4172/2155-9562.1000423 |
0.304 |
|
2017 |
Atassi N, Xu M, Triantafyllou C, Keil B, Lawson R, Cernasov P, Ratti E, Long CJ, Paganoni S, Murphy A, Salibi N, Seethamraju R, Rosen B, Ratai EM. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. Plos One. 12: e0177680. PMID 28498852 DOI: 10.1371/Journal.Pone.0177680 |
0.347 |
|
2016 |
O'Reilly ÉJ, Liu D, Johns DR, Cudkowicz ME, Paganoni S, Schwarzschild MA, Leitner M, Ascherio A. Serum urate at trial entry and ALS progression in EMPOWER. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27677562 DOI: 10.1080/21678421.2016.1214733 |
0.309 |
|
2015 |
Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C. Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis. Neurologic Clinics. 33: 909-36. PMID 26515629 DOI: 10.1016/J.Ncl.2015.07.008 |
0.357 |
|
2015 |
Paganoni S, Karam C, Joyce N, Bedlack R, Carter GT. Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. Neurorehabilitation. 37: 53-68. PMID 26409693 DOI: 10.3233/Nre-151240 |
0.333 |
|
2014 |
Paganoni S, Cudkowicz M, Berry JD. Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation. 4: 605-618. PMID 28203356 DOI: 10.4155/Cli.14.52 |
0.329 |
|
2014 |
Andrews JA, Paganoni S, Braastad C, Cudkowicz M, Atassi N. Disease burden in upper motor neuron syndromes: a survey of patient perspectives. Journal of Clinical Neuromuscular Disease. 16: 104-5. PMID 25415523 DOI: 10.1097/Cnd.0000000000000051 |
0.302 |
|
2014 |
Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review. The American Journal of Hospice & Palliative Care. PMID 25202033 DOI: 10.1177/1049909114548719 |
0.304 |
|
2014 |
Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, Cudkowicz M, Atassi N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 15: 453-6. PMID 24981792 DOI: 10.3109/21678421.2014.903974 |
0.309 |
|
2014 |
Jawaid A, Paganoni S, Hauser C, Schulz PE. Trials of antidiabetic drugs in amyotrophic lateral sclerosis: proceed with caution? Neuro-Degenerative Diseases. 13: 205-8. PMID 24107404 DOI: 10.1159/000353158 |
0.348 |
|
2012 |
Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. What does body mass index measure in amyotrophic lateral sclerosis and why should we care? Muscle & Nerve. 45: 612. PMID 22431098 DOI: 10.1002/Mus.22338 |
0.304 |
|
2011 |
Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle & Nerve. 44: 20-4. PMID 21607987 DOI: 10.1002/Mus.22114 |
0.331 |
|
2010 |
Paganoni S, Bernstein J, Ferreira A. Ror1-Ror2 complexes modulate synapse formation in hippocampal neurons. Neuroscience. 165: 1261-74. PMID 19958813 DOI: 10.1016/J.Neuroscience.2009.11.056 |
0.512 |
|
2005 |
Paganoni S, Ferreira A. Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. Journal of Cell Science. 118: 433-46. PMID 15654020 DOI: 10.1242/Jcs.01622 |
0.509 |
|
2004 |
Paganoni S, Anderson KL, Ferreira A. Differential subcellular localization of Ror tyrosine kinase receptors in cultured astrocytes. Glia. 46: 456-66. PMID 15095375 DOI: 10.1002/Glia.20023 |
0.477 |
|
2003 |
Paganoni S, Ferreira A. Expression and subcellular localization of Ror tyrosine kinase receptors are developmentally regulated in cultured hippocampal neurons. Journal of Neuroscience Research. 73: 429-40. PMID 12898527 DOI: 10.1002/Jnr.10674 |
0.508 |
|
2002 |
Ferreira A, Paganoni S. The formation of synapses in the central nervous system. Molecular Neurobiology. 26: 69-79. PMID 12392057 DOI: 10.1385/Mn:26:1:069 |
0.476 |
|
Show low-probability matches. |